Hackensack Healthcare Providers Settle Investigation with OAG Following Two Data Breaches TAPinto.net
Source: www.tapinto.net – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
